15-valent HPV vaccine

Human papillomavirus vaccine, 15-valent · Shanghai Bovax Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 15-valent HPV vaccine, covering 2025-01-06 to 2025-01-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years [Phase 1]

See pricing